Agilon Health Inc. (AGL) Misses Q2 EPS by 2c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $1.15 billion versus the consensus estimate of $1.11 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Sun Communities completes $1.03B sale of Park Holidays to Aermont
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals